随着我国人口老龄化和糖尿病、高血压等疾病的患病率逐年增高，慢性肾脏病的患病率也呈现不断上升之势。慢性肾脏病（CKD）是一类具有高发病率、高死亡率的慢性疾病群，严重威胁人类的健康。据统计，我国成人 CKD 患病率为 8.2%，但对CKD的知晓率仅为10%。2026年2月2日，据中国国家药品审评中心（CDE）官网显示，江苏豪森药业集团有限公司申报的1类新药HS-10390片新适应症临床试验申请获默示...
Source Link随着我国人口老龄化和糖尿病、高血压等疾病的患病率逐年增高，慢性肾脏病的患病率也呈现不断上升之势。慢性肾脏病（CKD）是一类具有高发病率、高死亡率的慢性疾病群，严重威胁人类的健康。据统计，我国成人 CKD 患病率为 8.2%，但对CKD的知晓率仅为10%。2026年2月2日，据中国国家药品审评中心（CDE）官网显示，江苏豪森药业集团有限公司申报的1类新药HS-10390片新适应症临床试验申请获默示...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.